US equities |
SPCX $168.74 ▲+6.15% NVDA $237.56 ▲+1.54% MU $1,064.60 ▼-0.96% TSLA $380.96 ▲+2.80% MSFT $524.75 ▲+1.40% SNDK $1,714.41 ▼-0.32% INTC $116.86 ▼-2.07% META $744.34 ▲+2.23%
FinancialContent

Monopar Therapeutics Inc. - Common Stock (NQ:MNPR)

78.70 +0.73 (+0.94%)
Delayed Quote Updated: 1:38 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Monopar Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Crude Oil Down 2%; Maravai LifeSciences Shares Spike Higher ↗
U.S. stocks traded mostly higher midway through trading, with the Dow Jones index jumping more than 100 points on Friday. The Dow traded up 0.36% to 39,209.32 while the NASDAQ rose 0.01% to 16,042.80.... 
Via Benzinga
Topics Stocks
News headline image
Dow Surges Over 150 Points; AerCap Posts Upbeat Earnings ↗
U.S. stocks traded higher this morning, with the Dow Jones index jumping more than 150 points on Friday. 
Via Benzinga
Topics Stocks
News headline image
Dow Gains Over 400 Points; Keurig Dr Pepper Shares Fall After Q4 Results ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones index jumping more than 400 points on Thursday. The Dow traded up 1.13% to 39,048.47 while the NASDAQ rose 2.93% to 16,037.52.... 
Via Benzinga
Topics Stocks
News headline image
What's Going On With Cancer-Focused Monopar Therapeutics Stock Today? ↗
Monopar Therapeutics soars 36% in premarket trading on robust volume. Exciting preclinical data reveals MNPR-101's potent anti-tumor efficacy in targeting uPAR-expressing cancers. 
Via Benzinga
News headline image
Recap: Monopar Therapeutics Q3 Earnings ↗
 
Via Benzinga
News headline image
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Etsy, Inc. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Rises 1%; US Jobless Claims Fall To 201,000 ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping around 300 points on Thursday. The Dow traded up 0.67% to 38,872.01 while the NASDAQ rose 2.36% to 15,949.22. The S&P... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers
From Monopar Therapeutics Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Crude Oil Moves Lower; Summit Therapeutics Shares Plummet ↗
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday. The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The... 
Via Benzinga
Topics Stocks
News headline image
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results. 
Via Benzinga
News headline image
Why Is Cancer Drug Focused Monopar Therapeutics Stock Trading Higher On Tuesday? ↗
Monopar Therapeutics surges 90% premarket with 3.94 million volume after HREC clearance for Phase 1 dosimetry trial (MNPR-101-Zr) in advanced cancers. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Dow Dips Over 100 Points; US Leading Economic Index Falls In January ↗
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 1.5% on Tuesday. The Dow traded down 0.35% to 38,494.51 while the NASDAQ fell 1.51% to 15,537.95. The S&P 500... 
Via Benzinga
Topics Stocks
News headline image
Nasdaq Down 1%; Capital One Set To Buy Discover ↗
U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.05% to 38,607.53 while the NASDAQ fell... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers
From Monopar Therapeutics Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results. 
Via Benzinga
News headline image
Why StoneCo Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket ↗
StoneCo Ltd. (NASDAQ: STNE) shares rose in pre-market trading after the company reported upbeat results for its third quarter on Friday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments
MNPR-101 Radiopharma Program to Enter First-in-Human Studies Potentially As Early As December of This Year Camsirubicin Phase 1b Trial Efficacy and Safety Data Highlighted at the 2023 CTOS Annual... 
From Monopar Therapeutics Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >